FLGT
Fulgent Genetics Inc

5,718
Mkt Cap
$484.39M
Volume
397,151.00
52W High
$31.04
52W Low
$13.46
PE Ratio
-7.89
FLGT Fundamentals
Price
$16.20
Prev Close
$15.51
Open
$15.77
50D MA
$22.12
Beta
0.77
Avg. Volume
362,514.68
EPS (Annual)
-$1.97
P/B
0.43
Rev/Employee
$240,082.59
$475.20
Loading...
Loading...
News
all
press releases
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
The law firm of Kirby McInerney LLP is investigating potential claims against Fulgent Genetics Inc. (Fulgent or the Company) (NASDAQ:FLGT). The investigation concerns whether the Company and/or...
Business Wire·6d ago
News Placeholder
More News
News Placeholder
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced the completion...
Business Wire·6d ago
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Stock Price Crosses Below 50-Day Moving Average - Here's Why
Fulgent Genetics (NASDAQ:FLGT) Stock Price Passes Below 50-Day Moving Average - Should You Sell...
MarketBeat·6d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent...
PR Newswire·18d ago
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS
Fulgent Genetics (NASDAQ:FLGT - Get Free Report) issued its earnings results on Friday. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by...
MarketBeat·23d ago
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2026 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY 2026 earnings guidance. The company provided EPS guidance of -1.450--1.450 for the period, compared to the consensus estimate of -0.590. The company also...
MarketBeat·24d ago
News Placeholder
Fulgent Genetics Q4 Earnings Call Highlights
Fulgent Genetics (NASDAQ:FLGT) used its fourth-quarter and full-year 2025 earnings call to outline continued growth in its laboratory services business, accelerating investments in digital pathology...
MarketBeat·24d ago
News Placeholder
Fulgent Genetics (FLGT) Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·24d ago
News Placeholder
Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +433.33% and -2.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·24d ago
News Placeholder
Fulgent Genetics Q4 Earnings Assessment
read more...
Benzinga·24d ago
<
1
2
...
>

Latest FLGT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.